Yes, pre-clinical, I think when Imugene say "Imugene will announce further detail from these abstracts at the time of the event" what we may see IMO on the 8-12th November is a new ANN titling:
"Imugene's Completed onCARlytics Investigational Studies Show Encouraging Results and Flags Three New Phase 1 Trials"
Another reason why Imugene sought more funding I believe. Yes, the Annual report said we had the available funds for the existing pipeline, but what if we keep marrying our platform off to other CD19 dance partners? 3 new P1's now, how many more investigational studies will come from this? Even if we half the costs with Eureka/Cellularity etc for the P1's, these could really add up.
A portion of the $80m could be going towards the partnership with ABL, but I see this partnership as more of a building block and a regulatory necessity rather than a done deal. I think we have funding for the next phase 2 study but IMU will probably have to come knocking again for phase 3 funding, which will most certainly be taken up by shareholders with grins from ear to ear!!
All in my opinion of course.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-6971
-
- There are more pages in this discussion • 8,758 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 5443565 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 2171910 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 4613688 | 0.048 |
36 | 4066646 | 0.047 |
46 | 3070983 | 0.046 |
60 | 6170008 | 0.045 |
11 | 1951364 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 1200533 | 2 |
0.050 | 4130537 | 15 |
0.051 | 6179811 | 13 |
0.052 | 2579418 | 10 |
0.053 | 1158504 | 8 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
IMU (ASX) Chart |